第一单位：
Department of Hematology and Oncology, University Medical Center, Faculty of Medicine, Freiburg, Germany.
作者：
Hana,Andrlová [1]
;
Justin,Mastroianni [1]
;
Josef,Madl [2]
;
Johannes S,Kern [3]
;
Wolfgang,Melchinger [1]
;
Heide,Dierbach [1]
;
Florian,Wernet [1]
;
Marie,Follo [1]
;
Kristin,Technau-Hafsi [3]
;
Cristina,Has [3]
;
Venugopal,Rao Mittapalli [3]
;
Marco,Idzko [4]
;
Ricarda,Herr [5]
;
Tilman,Brummer [5]
;
Hendrik,Ungefroren [6]
;
Hauke,Busch [7]
;
Melanie,Boerries [8]
;
Andreas,Narr [9]
;
Gabriele,Ihorst [10]
;
Claire,Vennin [11]
;
Annette,Schmitt-Graeff [12]
;
Susana,Minguet [9]
;
Paul,Timpson [11]
;
Justus,Duyster [1]
;
Frank,Meiss [3]
;
Winfried,Römer [2]
;
Robert,Zeiser [13]
作者单位：
Department of Hematology and Oncology, University Medical Center, Faculty of Medicine, Freiburg, Germany.
[1]
Faculty of Biology, Albert Ludwigs University, Freiburg, Germany.;BIOSS Centre for Biological Signalling Studies, Albert Ludwigs University Freiburg, Freiburg, Germany.
[2]
Department of Dermatology and Venereology, University Medical Center, Freiburg, Germany.
[3]
Department of Pneumology, University Medical Center, Freiburg, Germany.
[4]
Institut für Molekulare Medizin und Zellforschung, University Medical Center, Freiburg, Germany.
[5]
First Department of Medicine, University of Lübeck, Lübeck, Germany.
[6]
First Department of Medicine, University of Lübeck, Lübeck, Germany.;German Cancer Consortium (DKTK), Freiburg, Germany.;Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.;German Cancer Research Center (DKFZ), Heidelberg, Germany.
[7]
Institut für Molekulare Medizin und Zellforschung, University Medical Center, Freiburg, Germany.;German Cancer Consortium (DKTK), Freiburg, Germany.;German Cancer Research Center (DKFZ), Heidelberg, Germany.
[8]
Department of Immunology, BIOSS Center for Biological Signaling Studies, Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.;Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty, Freiburg, Germany.
[9]
Clinical Trials Unit, University Medical Center, Freiburg, Germany.
[10]
The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, Australia.
[11]
Department of Pathology, University Medical Center, Faculty of Medicine, Freiburg, Germany.
[12]
Department of Hematology and Oncology, University Medical Center, Faculty of Medicine, Freiburg, Germany.;BIOSS Centre for Biological Signalling Studies, Albert Ludwigs University Freiburg, Freiburg, Germany.
[13]
主题词
动物(Animals);双糖链蛋白多糖(Biglycan);细胞系, 肿瘤(Cell Line, Tumor);疾病模型, 动物(Disease Models, Animal);女(雌)性(Female);成纤维细胞(Fibroblasts);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);男(雄)性(Male);黑色素瘤(Melanoma);黑色素瘤, 实验性(Melanoma, Experimental);小鼠(Mice);小鼠, 基因敲除(Mice, Knockout);肿瘤侵润(Neoplasm Invasiveness);预后(Prognosis);存活率分析(Survival Analysis);肿瘤微环境(Tumor Microenvironment)
DOI
10.18632/oncotarget.17160
PMID
28476030
发布时间
2022-01-29
换一批
换一批
